ClinicalTrials.govpublic full text
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
adenocarcinoma, prostate cancer, neoplasms, carcinoma, neoplasms, glandular and epithelial, neoplasms by histologic type
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 390923
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.